L.et al (2017)
Clinical Evidence: Oral Versus Injectable Tirzepatide Outcomes Most weight loss efficacy data comes from studies using injectable tirzepatide, such as the SURMOUNT trials, which showed consistent dose-dependent weight reduction
Your treatment plan may contain several modalities to help draw symptom relief from, including acupuncture, Western medicine, naturopathy, hormone replacement therapies, vitamin injection therapies and intravenous therapy drips
The clinical trial data showed that using a lower starting dose (2 mg vs 4 mg initial) significantly reduced the incidence and severity of these symptoms
Regular physical activity, stress management, and adequate sleep all contribute to successful weight loss and improved well-being
In this case, a faster titration to the standard 2.5 mg starting dose may be more appropriate